BioNTech
BioNTech is a German biotechnology company that gained international recognition for its pioneering work on mRNA-based therapeutics and vaccines. Established in 2008, the company became a leading player in the fight against COVID-19 through its partnership with Pfizer to develop the BNT162b2 vaccine, one of the first vaccines authorized for emergency use against the virus. BioNTech's innovative approach and rapid development timeline during the pandemic have positioned it as a key player in the pharmaceutical industry.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Turkey | 1 | 7.00 | 0.07% | +0% | 84,339,067 | 57,727 | $720,000 | 493$ |
| Totals | 1 | 84,339,067 | 57,727 | $720,000 | 493$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Turkey:
BioNTech is collaborating with BMS to develop and commercialize a cancer drug.
7
France:
BioNTech is one of the three main stars in the anti-Covid-19 saga.
9